article thumbnail

Why small particles matter: Manufacturing and micro-material contamination

Pharmaceutical Technology

To protect patient safety and reduce recall risks, drug manufacturers must reduce particle contamination sources wherever possible.

article thumbnail

The Role of Good Manufacturing Practice (GMP) in Generic Drug Manufacturing: Ensuring Quality and Safety

Drug Patent Watch

The Unseen Heroes of Generic Drug Manufacturing: Good Manufacturing Practice (GMP) As we navigate the complex world of generic drug manufacturing, it's easy to overlook the unsung heroes that ensure the quality and safety of these life-saving medications. But what exactly does GMP entail?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA cites Emergent for failings at plant that contaminated J&J doses

Bio Pharma Dive

A recent nine-day inspection by agency officials found numerous breaches of manufacturing standards and inadequate training for factory employees.

article thumbnail

Keeping cleanrooms clean: Choosing the right laboratory equipment is key

Bio Pharma Dive

Because live cell and tissue products are extremely sensitive to contamination from microorganisms, viral particles or other airborne impurities, research and manufacturing involving these materials needs to be conducted in a cleanroom environment.

article thumbnail

GSK manufacturing review prompts Scynexis to pull Brexafemme, halt trials over contamination concerns

Fierce Pharma

GSK manufacturing review prompts Scynexis to pull Brexafemme, halt trials over contamination concerns esagonowsky Mon, 09/25/2023 - 12:26

article thumbnail

Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection

Fierce Pharma

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing reprimand from the FDA is alarming no matter which way you look at it. The FDA’s report cites six observations around poor quality control procedures, subpar cleaning, cross-contamination risks and more. 26 to Sept.

article thumbnail

FDA cracks down on China's Hengrui in scathing manufacturing write-up

Fierce Pharma

When the FDA comes knocking at your drug manufacturing facility, it’s best to play along. |